Rather, Peptide 2 supplementation improves IR and rescues insulin-regulated lipolysis in WAT while tending to reduce LD area, decreasing inflammation, and possibly preventing fibrosis, crucial processes to prevent NAFLD progression to NASH. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.